Germany's Lanxess -- spun off from Bayer at the beginning of the year -- is restructuring in hopes of cutting out about $73.8 million in costs. The chemicals manufacturer plans to realign facilities in the US and Europe, shuttering some and cutting 450 jobs.
- read this report from AFX for more